Business and Finance

Mourenx location will install new equipment, add hires in project as part of the France Relance recovery plan

Roche repeats at No. 1 position; AbbVie vaults five spots

Acquisition to expand presence in genomic medicine

Aims to enhance company's mRNA and viral vector capabilities

Horizon Therapeutics to purchase production facility from Irish specialty care company

How emerging life sciences organizations can create value with suppliers

How the pharma serialization and track-and-trace sector can be better prepared, should the world be unlucky enough to experience another global crisis

Health insurer Anthem joins BCBS organizations to form CivicaScript

Project SKY features one of Europe’s largest facilities for advanced therapies, says CDMO

Via remote data capture, alliance aids outcomes data collection for patients undergoing treatment

Will help UK consortium advance oral solid dosage medicines production

CDMO's Germany facility will supply starting material as part of manufacturing deal

Acquisition of Walgreens Boots Alliance's wholesaling business extends ABC’s pharma manufacturing and distribution reach

Merger with Oblikue Consulting gives specialist provider greater European and LATAM exposure for pricing and reimbursement

Will support pharma manufacturers with digital health and commercialization services

Company unifies its patient support services

Collaboration to focus on merging data with machine learning to make healthcare content more accessible

Pact between CPI and Cambridge Design Partnership aims to streamline the innovation-to-commercialization journey

Facility will house 44,000 square feet of clinical and commercial cGMP, and other tech services

Third deal in two months for the CRO expands capabilities in cell and gene therapy

Pharma and nutraceuticals collaborate, as deal introduces logistics program to Bonne Santé Group

Research report: 41% of US cannabis consumers self-identify as medical consumers

Portrix acquisition strengthens company’s supply chain presence

Will use new facility in Belgium for commercial production of plasmid DNA

The drive for “vaccine equity” around the world is strengthening efforts to limit patent protections on innovative drugs and vaccines to combat Covid